Grifols, S.A. (GIKLY)

USD 5.13

(0.0%)

Total Assets Summary of Grifols, S.A.

  • Grifols, S.A.'s latest annual total assets in 2023 was 21.45 Billion EUR , down -0.37% from previous year.
  • Grifols, S.A.'s latest quarterly total assets in 2024 Q1 was 21.95 Billion EUR , up 2.32% from previous quarter.
  • Grifols, S.A. reported annual total assets of 21.53 Billion EUR in 2022, up 11.96% from previous year.
  • Grifols, S.A. reported annual total assets of 19.23 Billion EUR in 2021, up 25.92% from previous year.
  • Grifols, S.A. reported quarterly total assets of 22.29 Billion EUR for 2024 Q2, up 1.54% from previous quarter.
  • Grifols, S.A. reported quarterly total assets of 21.45 Billion EUR for 2023 Q4, down -2.76% from previous quarter.

Annual Total Assets Chart of Grifols, S.A. (2023 - 2005)

Historical Annual Total Assets of Grifols, S.A. (2023 - 2005)

Year Total Assets Total Assets Growth
2023 21.45 Billion EUR -0.37%
2022 21.53 Billion EUR 11.96%
2021 19.23 Billion EUR 25.92%
2020 15.27 Billion EUR -1.72%
2019 15.54 Billion EUR 24.57%
2018 12.47 Billion EUR 14.26%
2017 10.92 Billion EUR 7.8%
2016 10.12 Billion EUR 5.5%
2015 9.6 Billion EUR 13.63%
2014 8.44 Billion EUR 44.66%
2013 5.84 Billion EUR 3.79%
2012 5.62 Billion EUR -3.1%
2011 5.8 Billion EUR 207.45%
2010 1.88 Billion EUR 13.99%
2009 1.65 Billion EUR 40.41%
2008 1.18 Billion EUR 25.61%
2007 939.56 Million EUR 2.83%
2006 913.67 Million EUR 11.2%
2005 821.68 Million EUR 0.0%

Peer Total Assets Comparison of Grifols, S.A.

Name Total Assets Total Assets Difference
AstraZeneca PLC 100.97 Billion USD 78.753%
Bristol-Myers Squibb Company PFD CONV 2 95.15 Billion USD 77.454%
CSPC Pharmaceutical Group Limited 6.52 Billion USD -228.857%
Clarus Therapeutics Holdings, Inc. 51.7 Million USD -41391.974%
Novartis AG 99.94 Billion USD 78.534%
PT Kalbe Farma Tbk. 1.75 Billion USD -1119.887%